![PDF] Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f825b000777a15ee38571331fdd5db403cb72a63/3-Table1-1.png "PDF] Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI | Semantic Scholar")
PDF] Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI | Semantic Scholar
Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis - ScienceDirect
HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis | Neurological Research and Practice ...
1930-R-MPV/high dose cytarabine overview | eviQ
Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents. - Abstract - Europe PMC
968-Methotrexate and cytarabine SUPERSEDED | eviQ
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet
Frontiers | Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China
High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials | Scientific Reports
Frontiers | Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China
Evolving Treatments for Primary Central Nervous System Lymphoma | American Society of Clinical Oncology Educational Book
Primary CNS lymphoma - ScienceDirect
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma | Blood Cancer Journal
Overview of regimens and cumulative doses of ara-C and anthracyclines... | Download Scientific Diagram
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse | Blood Cancer Journal
Figure 1 from Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche ...
A) Progression-free survival according to treatment with CNS-intensive... | Download Scientific Diagram
How we treat primary central nervous system lymphoma - ESMO Open
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement | SpringerLink
Cancers | Free Full-Text | A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma
HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis | Neurological Research and Practice ...
Cancers | Free Full-Text | A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma
Comparison of leukemia prognostic features among arm C patients with... | Download Table
Cancers | Free Full-Text | High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity
Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives
